DEUTSCHE BANK AG\ - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 45 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$63,000
-67.0%
14,349
-10.6%
0.00%
Q4 2021$191,000
+154.7%
16,047
+268.8%
0.00%
Q3 2021$75,000
-3.8%
4,351
-3.1%
0.00%
Q2 2021$78,0004,4920.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders